First Time Loading...

Deciphera Pharmaceuticals Inc
NASDAQ:DCPH

Watchlist Manager
Deciphera Pharmaceuticals Inc Logo
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Watchlist
Price: 25.385 USD 0.02% Market Closed
Updated: May 3, 2024

Deciphera Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Deciphera Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Cash from Financing Activities
$152m
CAGR 3-Years
-12%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Deciphera Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
152m USD

Based on the financial report for Dec 31, 2023, Deciphera Pharmaceuticals Inc's Cash from Financing Activities amounts to 152m USD.

What is Deciphera Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-4%

Over the last year, the Cash from Financing Activities growth was -8%. The average annual Cash from Financing Activities growth rates for Deciphera Pharmaceuticals Inc have been -12% over the past three years , -4% over the past five years .